Thursday 25th April 2024

US recommends ‘pause’ for J&J vaccine over clot reports

tmpe30c33c8-175a-42b1-8c23-a2971f7579fd-jpg
tmpe30c33c8-175a-42b1-8c23-a2971f7579fd-jpg

WASHINGTON (AP) — The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

Two vaccination clinics were held at Ralph Bunche Community Center in Glasgow where the Johnson & Johnson vaccine was administered. Over 200 people were vaccinated between the two clinics.

In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said it was investigating clots in six women in the days after vaccination, in combination with reduced platelet counts. More than 6.8 million doses of the J&J vaccine have been administered in the U.S.

U.S. federal distribution channels, including mass vaccination sites, will pause the use of the J&J shot, and states and other providers are expected to follow.

Loading...